Annual Symposium on Nonhuman Primates

非人类灵长类动物年度研讨会

• 批准号: 10676977
• 负责人: R. PAUL JOHNSON
• 金额: $ 7.5万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-15 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10676977
• 关键词: AIDS Vaccines; Acceleration; Acquired Immunodeficiency Syndrome; Address; Adult; Antibodies; Applications Grants; Budgets; COVID-19 pandemic; COVID-19 pathogenesis; COVID-19 treatment; COVID-19 vaccine; California; Child; Clinic; Clinical; Collaborations; Communicable Diseases; Development; Disease; Emerging Technologies; Fees; Fostering; Funding; Future; Generations; Genomics; Grant; HIV; HIV Infections; HIV Vaccine Trials Network; HIV vaccine; HIV/AIDS; Health; Human; Hybrids; Immunologic Deficiency Syndromes; Immunology; Individual; International; Intervention; Journals; Knowledge; Life; Link; Logistics; Medical; Mentors; Mission; Modeling; NIH Vaccine Research Center; Oral; Oregon; Participant; Pathogenesis; Pennsylvania; Persons; Prevention; Preventive vaccine; Primates; Publishing; Research; Research Personnel; Role; Rotation; SIV; Scientific Advances and Accomplishments; Scientist; Technology; Testing; Translations; United States National Institutes of Health; Vaccines; Virus Diseases; Writing; antiretroviral therapy; co-infection; coronavirus disease; cost; disability; experience; falls; global health; meetings; neutralizing antibody; nonhuman primate; novel therapeutics; originality; posters; prevent; programs; response; symposium; therapy design; transmission process

PROJECT SUMMARY With this R13 application, we request funding to support, in part, the costs for planning, publicizing, and hosting the 39th, 40th, and 41st Annual Symposia on Nonhuman Primate Models for AIDS. For four decades, this symposium has served as the premier scientific forum for the exchange of information, including new research findings and scientific perspectives, among HIV/AIDS investigators whose research includes studies in nonhuman primates (NHPs). Disseminating the latest research findings in NHP models of AIDS while also facilitating discussion and exchange of information between basic scientists and clinicians remains a priority, as do focusing on emerging technologies to accelerate translation of NHP studies into the clinic and engaging a broader and more diverse group of researchers in HIV/AIDS research in NHP models. This meeting, the only one of its kind in the world, convenes an international group of scientists whose research focuses on the study of natural and experimental immunodeficiency virus infections in NHPs, as well as on the development of novel therapeutics, prophylactic vaccines for HIV, and curative approaches. Emerging topics in related infectious diseases (such as COVID-19 pathogenesis, vaccines and treatment) may also be included. The seven National Primate Research Centers (NPRCs) host this meeting in rotation, and upcoming symposia hosts will be the Yerkes (2022), California (2023), and Tulane (2024) NPRCs. We plan a hybrid format with most participants attending in person and others joining online to access oral and poster sessions. The conference will begin on day 1 with registration, a keynote address by a leading HIV/AIDS researcher, and an evening reception. The following two and a half days will include scientific presentations from invited speakers and accepted oral abstracts. Each symposium scientific committee will select session topics and speakers to highlight new and cutting-edge technologies in their respective fields. Each session will open with a 30-minute talk by an invited chair. Individuals whose abstracts are accepted for oral presentations will give the remaining session talks. A poster session will occur on the evening of day 2, and there will be a banquet on the evening of day 3. As is traditional for this symposium, the Journal of Medical Primatology will publish all poster and oral abstracts in a special issue. In partnership with the HIV Vaccine Trials Network (HVTN), the NHP AIDS Symposium will also host a pre-symposium meeting for early stage investigators (ESI). This meeting will be open to the attendees of a linked ESI Conference the HVTN sponsors. ESI attendees and mentors will focus on grant writing, budgeting, and networking, and will participate in a Q&A with NIH Program Officers. We believe bringing together researchers from a variety of diverse backgrounds will generate future collaborations and scientific advances. Knowledge shared and gained at upcoming Annual Nonhuman Primate Models for AIDS Symposia will further the continued, effective use of NHP models to maintain long term control of HIV replication in the absence of antiretroviral therapy and to design interventions to prevent or eradicate HIV infection.

项目概要 通过此 R13 申请，我们请求资金来支持部分规划、宣传和托管费用 第 39 届、第 40 届和第 41 届艾滋病非人类灵长类动物模型年度研讨会。四十年来，这 研讨会已成为交流信息（包括新研究）的首要科学论坛 艾滋病毒/艾滋病调查人员的研究结果和科学观点，其研究包括 非人类灵长类动物（NHP）。传播 NHP 艾滋病模型的最新研究成果，同时也 促进基础科学家和临床医生之间的讨论和信息交流仍然是一个优先事项， 重点关注新兴技术以加速 NHP 研究转化为临床并参与 在 NHP 模型中进行艾滋病毒/艾滋病研究的更广泛、更多样化的研究人员群体。此次会议，是唯一 世界上同类之一，召集了一个国际科学家小组，其研究重点是该研究 NHP 中自然和实验性免疫缺陷病毒感染的研究，以及新型疫苗的开发 治疗方法、艾滋病毒预防性疫苗和治疗方法。相关传染病的新兴话题 疾病（例如 COVID-19 发病机制、疫苗和治疗）也可能包括在内。七国 灵长类动物研究中心 (NPRC) 轮流主办本次会议，即将召开的研讨会主办方将是 耶克斯 (2022)、加利福尼亚州 (2023) 和杜兰 (2024) NPRC。我们计划采用混合形式，吸引大多数参与者 亲自参加，其他人在线参加口头和海报会议。会议将于 第一天包括登记、领先的艾滋病毒/艾滋病研究人员的主题演讲以及晚间招待会。这 接下来的两天半将包括受邀演讲者的科学演讲和接受的口头演讲 摘要。每次研讨会科学委员会将选择会议主题和演讲者，以突出新的和 各自领域的尖端技术。每场会议将以受邀嘉宾的 30 分钟演讲开始 椅子。摘要被接受进行口头报告的个人将在剩余的会议上进行演讲。一个 海报会议将在第 2 天晚上进行，第 3 天晚上将有宴会。 按照本次研讨会的传统，《医学灵长类动物学杂志》将在 专刊。 NHP 艾滋病研讨会还将与 HIV 疫苗试验网络 (HVTN) 合作 为早期研究人员 (ESI) 举办一次研讨会前会议。本次会议将向与会者开放 HVTN 赞助的相关 ESI 会议。 ESI 与会者和导师将专注于资助写作、 预算和网络，并将参加与 NIH 项目官员的问答。我们相信带来 来自不同背景的研究人员将共同产生未来的合作和科学 进步。在即将举行的年度非人类灵长类艾滋病模型研讨会上分享和获得的知识 将进一步持续、有效地使用 NHP 模型，以维持对 HIV 复制的长期控制 缺乏抗逆转录病毒治疗并设计干预措施来预防或根除艾滋病毒感染。